Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
INhance Post-injection Serum is a topical serum developed by ALASTIN Skincare, designed to accelerate recovery from post-injection bruising and swelling, and to improve overall skin quality and texture. It incorporates proprietary technologies such as TriHex Technology®, a blend of active peptides that supports the skin's natural production of elastin, collagen, and hyaluronic acid, and ChromaFADE Technology™, which aids in the rapid clearance of bruise-related debris. The serum also contains a combination of botanicals like Arnica Montana and Ledum Palustre extracts to reduce inflammation, redness, and swelling, alongside other active ingredients including Lactoferrin, Phosphatidylserine, Sodium Hyaluronate, Hexapeptide-38, and Xylitol, which collectively contribute to bruise resolution, skin hydration, and regeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on INhance Post-injection Serum.